12/17/2025
On December 16, 2025, over 70 healthcare professionals, including both doctors and advanced practice providers, attended a presentation on Hemodiafiltration. Fresenius is planning to introduce this innovative technology to the U.S. market in early 2026, with our clinics among the first nationwide to offer the therapy. Studies have demonstrated that Hemodiafiltration can reduce mortality rates in European ESRD patients by over 20%. Our providers were enthusiastic to gain insights from three leading national and international physician experts in this field.
